17.88
price down icon0.67%   -0.12
pre-market  Pre-market:  19.89   2.01   +11.24%
loading
Tourmaline Bio Inc stock is traded at $17.88, with a volume of 169.74K. It is down -0.67% in the last 24 hours and down -13.41% over the past month. Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
See More
Previous Close:
$18.00
Open:
$18.18
24h Volume:
169.74K
Relative Volume:
0.86
Market Cap:
$458.49M
Revenue:
-
Net Income/Loss:
$11.77M
P/E Ratio:
30.91
EPS:
0.5785
Net Cash Flow:
$-19.23M
1W Performance:
-3.87%
1M Performance:
-13.41%
6M Performance:
+21.55%
1Y Performance:
-43.20%
1-Day Range:
Value
$17.79
$18.85
1-Week Range:
Value
$17.00
$19.12
52-Week Range:
Value
$12.12
$48.31

Tourmaline Bio Inc Stock (TRML) Company Profile

Name
Name
Tourmaline Bio Inc
Name
Phone
646-481-9832
Name
Address
27 WEST 24TH STREET, NEW YORK
Name
Employee
74
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
TRML's Discussions on Twitter

Compare TRML with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TRML
Tourmaline Bio Inc
17.88 458.49M 0 11.77M -19.23M 0.5785
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-06-24 Initiated BMO Capital Markets Outperform
Nov-11-24 Reiterated H.C. Wainwright Buy
Dec-15-23 Initiated Jefferies Buy
Dec-04-23 Resumed H.C. Wainwright Buy
Nov-17-23 Initiated Truist Buy
Oct-31-23 Initiated Guggenheim Buy
Oct-25-23 Initiated Piper Sandler Overweight
Oct-20-22 Initiated H.C. Wainwright Buy
Jul-05-22 Downgrade Morgan Stanley Overweight → Equal-Weight
View All

Tourmaline Bio Inc Stock (TRML) Latest News

pulisher
Jan 17, 2025

Short Interest in Tourmaline Bio, Inc. (NASDAQ:TRML) Rises By 26.8% - MarketBeat

Jan 17, 2025
pulisher
Jan 16, 2025

Barclays PLC Purchases Shares of 73,897 Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG) - Defense World

Jan 16, 2025
pulisher
Jan 16, 2025

Barclays PLC Increases Position in Bit Digital, Inc. (NASDAQ:BTBT) - Defense World

Jan 16, 2025
pulisher
Jan 16, 2025

Barclays PLC Has $830,000 Stake in NerdWallet, Inc. (NASDAQ:NRDS) - Defense World

Jan 16, 2025
pulisher
Jan 16, 2025

Barclays PLC Purchases 190,520 Shares of Clean Energy Fuels Corp. (NASDAQ:CLNE) - Defense World

Jan 16, 2025
pulisher
Jan 16, 2025

Barclays PLC Raises Holdings in First Bank (NASDAQ:FRBA) - Defense World

Jan 16, 2025
pulisher
Jan 16, 2025

Barclays PLC Has $843,000 Holdings in Cantaloupe, Inc. (NASDAQ:CTLP) - Defense World

Jan 16, 2025
pulisher
Jan 16, 2025

Barclays PLC Has $819,000 Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Jan 16, 2025
pulisher
Jan 10, 2025

Tourmaline Bio Appoints Dr. Paul M. Ridker To Cardiovascular Scientific Advisory Board - citybiz

Jan 10, 2025
pulisher
Jan 10, 2025

Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker - The Manila Times

Jan 10, 2025
pulisher
Jan 01, 2025

Franklin Resources Inc. Makes New $339,000 Investment in ADT Inc. (NYSE:ADT) - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Vital Energy, Inc. (NYSE:VTLE) Stock Position Lifted by Franklin Resources Inc. - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

JPMorgan Chase & Co. Buys 34,072 Shares of Sun Life Financial Inc. (NYSE:SLF) - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Climb Global Solutions, Inc. (NASDAQ:CLMB) Stock Holdings Lifted by Barclays PLC - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Position Lifted by Geode Capital Management LLC - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

EDP – Energias de Portugal (OTCMKTS:EDPFY) Stock Price Crosses Below 200 Day Moving Average – Time to Sell? - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Barclays PLC Makes New Investment in Concentra Group Holdings Parent, Inc. (NYSE:CON) - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

PBF Energy Inc. (NYSE:PBF) Shares Sold by Principal Financial Group Inc. - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Barclays PLC Has $810,000 Stock Holdings in ACCO Brands Co. (NYSE:ACCO) - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Geode Capital Management LLC Trims Stock Position in Playtika Holding Corp. (NASDAQ:PLTK) - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Geode Capital Management LLC Purchases 29,005 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Jan 01, 2025
pulisher
Jan 01, 2025

Barclays PLC Acquires 4,125 Shares of NETGEAR, Inc. (NASDAQ:NTGR) - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Barclays PLC Raises Stock Holdings in Cantaloupe, Inc. (NASDAQ:CTLP) - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

StockNews.com Begins Coverage on Golden Minerals (NYSE:AUMN) - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Head to Head Review: VectivBio (NASDAQ:VECT) versus Tourmaline Bio (NASDAQ:TRML) - Defense World

Jan 01, 2025
pulisher
Dec 31, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Dec 31, 2024
pulisher
Dec 31, 2024

Tempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

Dec 31, 2024
pulisher
Dec 31, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Rating of “Buy” by Analysts - Defense World

Dec 31, 2024
pulisher
Dec 27, 2024

Stifel Financial Corp Lowers Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Dec 27, 2024
pulisher
Dec 27, 2024

State Street Corp Purchases 83,949 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Dec 27, 2024
pulisher
Dec 27, 2024

Grupo Financiero Banorte (OTCMKTS:GBOOF) Stock Price Crosses Below 200-Day Moving Average – What’s Next? - Defense World

Dec 27, 2024
pulisher
Dec 27, 2024

DTF Tax-Free Income 2028 Term Fund (NYSE:DTF) Stock Crosses Below Two Hundred Day Moving Average – Here’s Why - Defense World

Dec 27, 2024
pulisher
Dec 27, 2024

RBC Life Sciences (OTCMKTS:RBCL) Share Price Crosses Above 50-Day Moving Average – Here’s What Happened - Defense World

Dec 27, 2024
pulisher
Dec 27, 2024

Sprott Focus Trust (NASDAQ:FUND) Share Price Crosses Below 200-Day Moving Average – Here’s What Happened - Defense World

Dec 27, 2024
pulisher
Dec 27, 2024

European Assets Trust (LON:EAT) Stock Passes Below Two Hundred Day Moving Average – Here’s What Happened - Defense World

Dec 27, 2024
pulisher
Dec 27, 2024

Pressure BioSciences (OTCMKTS:PBIO) Share Price Passes Below Two Hundred Day Moving Average – What’s Next? - Defense World

Dec 27, 2024
pulisher
Dec 27, 2024

State Street Corp Has $10.59 Million Stake in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Dec 27, 2024
pulisher
Dec 27, 2024

ITOCHU (OTCMKTS:ITOCY) Share Price Passes Below Two Hundred Day Moving Average – What’s Next? - Defense World

Dec 27, 2024
pulisher
Dec 24, 2024

Tourmaline Bio (NASDAQ:TRML) Shares Down 3.9%What's Next? - MarketBeat

Dec 24, 2024
pulisher
Dec 20, 2024

Tourmaline Bio to host investor day - MSN

Dec 20, 2024
pulisher
Dec 20, 2024

Fmr LLC Has $387,000 Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Graves Ophthalmopathy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts - EIN News

Dec 20, 2024
pulisher
Dec 20, 2024

Fmr LLC Acquires 472 Shares of Vanguard S&P Mid-Cap 400 Growth ETF (NYSEARCA:IVOG) - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Tourmaline Bio, Inc. (NASDAQ:TRML) Stake Reduced by Fmr LLC - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

Eventbrite, Inc. (NYSE:EB) Shares Acquired by Fmr LLC - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

Wellington Management Group LLP Raises Stake in Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat

Dec 19, 2024
pulisher
Dec 17, 2024

The Manufacturers Life Insurance Company Acquires Shares of 11,631 Tredegar Co. (NYSE:TG) - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

The Manufacturers Life Insurance Company Buys 5,945 Shares of Orchid Island Capital, Inc. (NYSE:ORC) - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

The Manufacturers Life Insurance Company Takes $226,000 Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

The Manufacturers Life Insurance Company Sells 1,547 Shares of NB Bancorp, Inc. (NASDAQ:NBBK) - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

BNP Paribas Financial Markets Acquires 5,952 Shares of Hamilton Beach Brands Holding (NYSE:HBB) - Defense World

Dec 17, 2024

Tourmaline Bio Inc Stock (TRML) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Cap:     |  Volume (24h):